GENDELL JEFFREY L - FENNEC PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
GENDELL JEFFREY L ownership history of FENNEC PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,147,800
-14.2%
285,992
+0.9%
0.12%
-37.1%
Q2 2023$2,502,537
+19.2%
283,413
+12.3%
0.19%
-1.5%
Q1 2023$2,099,020
+42.8%
252,286
+64.8%
0.20%
+51.5%
Q4 2022$1,469,472153,0700.13%
Other shareholders
FENNEC PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Solas Capital Management, LLC 849,979$3,400,0003.47%
Southpoint Capital Advisors LP 3,997,214$15,989,0000.60%
Opaleye Management Inc. 295,000$1,180,0000.36%
683 Capital Management, LLC 971,351$3,885,0000.35%
Avoro Capital Advisors LLC 1,105,999$4,424,0000.15%
Eventide Asset Management 720,000$2,880,0000.09%
Granahan Investment Management 439,083$1,756,0000.09%
Hartford Financial Management Inc. 20,300$81,0000.03%
OXFORD ASSET MANAGEMENT LLP 75,236$301,0000.01%
Paloma Partners Management Co 54,400$218,0000.00%
View complete list of FENNEC PHARMACEUTICALS INC shareholders